FORA Capital’s Integra LifeSciences IART Stock Holding History

FORA Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,291	Closed	-$200K	–	578
2025 Q2	$200K	Buy	+16,291	New	+$237K	0.02%	455
2024 Q4	–	Sell	-24,004	Closed	-$436K	–	480
2024 Q3	$436K	Buy	+24,004	New	+$556K	0.05%	309
2024 Q2	–	Sell	-9,291	Closed	-$329K	–	447
2024 Q1	$329K	Buy	+9,291	New	+$372K	0.03%	366
2022 Q4	–	Sell	-6,561	Closed	-$278K	–	565
2022 Q3	$278K	Buy	+6,561	New	+$336K	0.05%	340
2021 Q2	–	Sell	-890	Closed	-$61K	–	996
2021 Q1	$61K	Buy	+890	New	+$60.3K	0.02%	516

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's IART Position: Q3 2025 in Review

FORA Capital sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 16,291 shares — an estimated $200K sold.

FORA Capital first reported a position in IART in Q1 2021 and held it in 5 quarters. The position peaked at $436K in Q3 2024. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

FORA Capital reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
FORA Capital sold 16,291 Integra LifeSciences shares in Q3 2025, an estimated $200K.
FORA Capital first reported a position in Integra LifeSciences in Q1 2021 and held it in 5 quarters.
FORA Capital's Integra LifeSciences position peaked at $436K in Q3 2024.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.